DE60124400D1 - Verwendung eines betablockers zur behandlung von atherosklerose - Google Patents
Verwendung eines betablockers zur behandlung von atheroskleroseInfo
- Publication number
- DE60124400D1 DE60124400D1 DE60124400T DE60124400T DE60124400D1 DE 60124400 D1 DE60124400 D1 DE 60124400D1 DE 60124400 T DE60124400 T DE 60124400T DE 60124400 T DE60124400 T DE 60124400T DE 60124400 D1 DE60124400 D1 DE 60124400D1
- Authority
- DE
- Germany
- Prior art keywords
- betablocker
- atherosclerosis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 239000002876 beta blocker Substances 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354 | 2000-06-22 | ||
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
PCT/SE2001/001380 WO2001097751A2 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60124400D1 true DE60124400D1 (de) | 2006-12-21 |
DE60124400T2 DE60124400T2 (de) | 2007-10-31 |
Family
ID=20280209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60124400T Expired - Fee Related DE60124400T2 (de) | 2000-06-22 | 2001-06-15 | Verwendung eines betablockers zur behandlung von atherosklerose |
Country Status (28)
Country | Link |
---|---|
US (2) | US20030191177A1 (de) |
EP (1) | EP1296716B1 (de) |
JP (1) | JP2003535875A (de) |
KR (1) | KR20030010750A (de) |
CN (1) | CN1437484A (de) |
AR (1) | AR028699A1 (de) |
AT (1) | ATE344675T1 (de) |
AU (1) | AU2001274766A1 (de) |
BG (1) | BG107373A (de) |
BR (1) | BR0111790A (de) |
CA (1) | CA2411100A1 (de) |
CZ (1) | CZ20024181A3 (de) |
DE (1) | DE60124400T2 (de) |
EE (1) | EE200200703A (de) |
ES (1) | ES2274892T3 (de) |
HK (1) | HK1054508A1 (de) |
HU (1) | HUP0302371A3 (de) |
IL (1) | IL153245A0 (de) |
IS (1) | IS6653A (de) |
MX (1) | MXPA02012957A (de) |
NO (1) | NO20026177L (de) |
NZ (1) | NZ523188A (de) |
PL (1) | PL360484A1 (de) |
RU (1) | RU2271802C2 (de) |
SE (1) | SE0002354D0 (de) |
SK (1) | SK18072002A3 (de) |
WO (1) | WO2001097751A2 (de) |
ZA (1) | ZA200209908B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1722780A4 (de) * | 2003-11-26 | 2008-12-17 | Univ Duke | Verfahren zur prävention oder behandlung von glaukom |
KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
KR100836321B1 (ko) | 2006-10-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 모니터 장치 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
WO1992016197A1 (en) * | 1991-03-18 | 1992-10-01 | Sepracor Inc. | Composition and method containing optically pure (s) metoprolol |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
NO177455C (no) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Anordning ved apparat for fremstilling av brannslukkende skum |
WO1997038694A1 (en) * | 1996-04-17 | 1997-10-23 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (sv) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
EP1140187B1 (de) * | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen |
-
2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
-
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 EP EP01941409A patent/EP1296716B1/de not_active Expired - Lifetime
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Application Discontinuation
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
-
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
-
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
-
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20026177D0 (no) | 2002-12-20 |
JP2003535875A (ja) | 2003-12-02 |
CA2411100A1 (en) | 2001-12-27 |
EP1296716B1 (de) | 2006-11-08 |
RU2271802C2 (ru) | 2006-03-20 |
BR0111790A (pt) | 2003-05-20 |
IL153245A0 (en) | 2003-07-06 |
HK1054508A1 (zh) | 2003-12-05 |
ATE344675T1 (de) | 2006-11-15 |
DE60124400T2 (de) | 2007-10-31 |
MXPA02012957A (es) | 2003-05-15 |
HUP0302371A3 (en) | 2007-03-28 |
HUP0302371A2 (hu) | 2003-11-28 |
US20060252814A1 (en) | 2006-11-09 |
IS6653A (is) | 2002-12-11 |
EE200200703A (et) | 2004-08-16 |
NZ523188A (en) | 2006-06-30 |
PL360484A1 (en) | 2004-09-06 |
NO20026177L (no) | 2002-12-20 |
WO2001097751A3 (en) | 2002-03-28 |
CN1437484A (zh) | 2003-08-20 |
US20030191177A1 (en) | 2003-10-09 |
SE0002354D0 (sv) | 2000-06-22 |
EP1296716A2 (de) | 2003-04-02 |
AR028699A1 (es) | 2003-05-21 |
ZA200209908B (en) | 2004-03-05 |
CZ20024181A3 (cs) | 2003-04-16 |
BG107373A (bg) | 2003-09-30 |
WO2001097751A2 (en) | 2001-12-27 |
KR20030010750A (ko) | 2003-02-05 |
SK18072002A3 (sk) | 2003-08-05 |
AU2001274766A1 (en) | 2002-01-02 |
ES2274892T3 (es) | 2007-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE265860T1 (de) | Impstoff zur behandlung von atherosclerosis | |
ATE394103T1 (de) | Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie | |
DE60035378D1 (de) | Gerät zur Behandlung von Bandscheiben | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
ATE538096T1 (de) | Pyridinon-derivate zur behandlung von arteriosklerose | |
DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE69924750D1 (de) | Gerät zur thermischen behandlung von gewebe | |
DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
DE60029033D1 (de) | Verfahren zur Behandlung von Tissuepapier | |
DE60234760D1 (de) | Phenylindole zur behandlung von hiv | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE69936890D1 (de) | Vorrichtung zur Behandlung von Ischämie | |
ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
DE50014041D1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
ATE254913T1 (de) | Diacerein zur behandlung von psoriasis | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE60030861D1 (de) | Verwendung von escitalopram zur Behandlung von generalisierten Angstzuständen | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
DE60104791D1 (de) | Cyclobutendion-Derivate zur Behandlung von Artherosclerose | |
DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |